Evidence map›Paper›PMID 25887615›Full record

ReviewCurrent opinion in infectious diseases2015

Rational development of guidelines for management of neonatal sepsis in developing countries.

Anna C Seale, Christina W Obiero, James A Berkley

Abstract readReview
In one paragraph

Review in Current opinion in infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Antibiotic regimens for early-onset neonatal sepsis.The Cochrane database of systematic reviews · 2021
    Pooled it
  2. Antibiotic regimens for late-onset neonatal sepsis.The Cochrane database of systematic reviews · 2021
    Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anna C SealeaDepartment of Infectious Diseases Informatics, UCL Institute for Health Informatics, Farr Institute, University College London bImperial NHS Trust, London, UK cKEMRI/Wellcome Trust Research Programme, Kilifi, Kenya dThe Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK.
Christina W Obiero
James A Berkley

Funding

Wellcome Trust 083579Wellcome Trust 092654
6 · The paper itself

Abstract

purpose of reviewThis review discusses the rational development of guidelines for the management of neonatal sepsis in developing countries. RECENT

findingsDiagnosis of neonatal sepsis with high specificity remains challenging in developing countries. Aetiology data, particularly from rural, community-based studies, are very limited, but molecular tests to improve diagnostics are being tested in a community-based study in South Asia. Antibiotic susceptibility data are limited, but suggest reducing susceptibility to first-and second-line antibiotics in both hospital and community-acquired neonatal sepsis. Results of clinical trials in South Asia and sub-Saharan Africa assessing feasibility of simplified antibiotic regimens are awaited. SUMMARY: Effective management of neonatal sepsis in developing countries is essential to reduce neonatal mortality and morbidity. Simplified antibiotic regimens are currently being examined in clinical trials, but reduced antimicrobial susceptibility threatens current empiric treatment strategies. Improved clinical and microbiological surveillance is essential, to inform current practice, treatment guidelines, and monitor implementation of policy changes.

Indexed as

Anti-Bacterial AgentsCommunity-Acquired InfectionsDeveloping CountriesFeasibility StudiesHumansInfantInfant MortalityInfant, NewbornPractice Guidelines as TopicSentinel SurveillanceSepsisTreatment OutcomeAnti-Bacterial Agents

Identifiers

PMID25887615
PMCPMC4423591

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.